Stay updated with breaking news from Marc Stapley. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Glaukos (NYSE:GKOS – Free Report) had its target price boosted by Citigroup from $120.00 to $130.00 in a research note released on Wednesday morning, Benzinga reports. The brokerage currently has a buy rating on the medical instruments supplier’s stock. Several other analysts have also issued reports on GKOS. JPMorgan Chase & Co. boosted their price […]
Glaukos (NYSE:GKOS – Get Free Report) was downgraded by StockNews.com from a “hold” rating to a “sell” rating in a research report issued on Tuesday. Other equities analysts also recently issued reports about the company. Morgan Stanley started coverage on Glaukos in a report on Monday, December 4th. They set an “equal weight” rating and […]
Glaukos (NYSE:GKOS – Free Report) had its price objective hoisted by Wells Fargo & Company from $83.00 to $103.00 in a research report report published on Thursday morning, Benzinga reports. They currently have an overweight rating on the medical instruments supplier’s stock. A number of other equities analysts have also recently weighed in on the […]
Glaukos (NYSE:GKOS – Get Free Report) issued its quarterly earnings data on Wednesday. The medical instruments supplier reported ($0.63) EPS for the quarter, missing the consensus estimate of ($0.56) by ($0.07), Briefing.com reports. The company had revenue of $82.40 million during the quarter, compared to the consensus estimate of $81.00 million. Glaukos had a negative […]
Veracyte, Inc. misses on earnings expectations. Reported EPS is $-0.39 EPS, expectations were $-0.07. Veracyte, Inc.